<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Leap Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Leap Therapeutics, Inc.

    Leap Therapeutics (NASDAQ: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leap's most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein, a Wnt pathway modulator. DKN-01 is in clinical trials in patients with esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap's second clinical candidate, TRX518, is a humanized GITR agonist monoclonal antibody designed to enhance the immune system's anti-tumor response that is in advanced solid tumor studies. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Chris Mirabelli, Ph.D.
    • FOUNDED
      2011
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Sienna Biopharmaceuticals, Inc.

    Sienna Biopharmaceuticals, Inc.

    Sienna Biopharmaceuticals, Inc. is a clinical–stage biopharmaceutical company fo...

    Sienna Biopharmaceuticals, Inc. is a clinicalâ€...

    Filing Type:    PU
    Eyegate Pharmaceuticals, Inc.

    Eyegate Pharmaceuticals, Inc.

    EyeGate is developing and commercializing products for treating diseases and disor...

    EyeGate is developing and commercializing produ...

    Filing Type:    PU
    Carolina Complete Health Network, Inc

    Carolina Complete Health Network, Inc

    Carolina Complete Health Network, Inc was created to offer a patient-focused Medic...

    Carolina Complete Health Network, Inc was creat...

    Fundraising Status:    EC
    Filing Type:    RA
    Trevi Therapeutics, Inc.

    Trevi Therapeutics, Inc.

    We are developing nalbuphine ER to treat serious neurologically mediated condition...

    We are developing nalbuphine ER to treat seriou...

    Filing Type:    PU
    Akero Therapeutics, Inc.

    Akero Therapeutics, Inc.

    Akero aims to develop and deliver transformational medicines to patients with high...

    Akero aims to develop and deliver transformatio...

    Filing Type:    PU
    Madrigal Pharmaceuticals, Inc.

    Madrigal Pharmaceuticals, Inc.

    Madrigal Pharmaceuticals is a clinical-stage biopharmaceutical company pursuing no...

    Madrigal Pharmaceuticals is a clinical-stage bi...

    Filing Type:    PU
    IGM Biosciences, Inc.

    IGM Biosciences, Inc.

    Headquartered in Mountain View, California, IGM Biosciences is a biotechnology com...

    Headquartered in Mountain View, California, IGM...

    Filing Type:    PU
    BeyondSpring, Inc.

    BeyondSpring, Inc.

    Headquartered in New York, BeyondSpring Inc. (BeyondSpring) is a global, clinical-...

    Headquartered in New York, BeyondSpring Inc. (B...

    Filing Type:    PU
    Allogene Therapeutics, Inc.

    Allogene Therapeutics, Inc.

    Allogene Therapeutics is a clinical stage biotechnology company pioneering the dev...

    Allogene Therapeutics is a clinical stage biote...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.